About Us

Products & Services

News & Events

Investor Relations

Bio-Molecular Laboratory Services for the
Discovery, Development and Manufacturing of
Biologics and Speciality Diagnostics

Current News

2006-2008
Archived News

2005

2004

2003

2002

News and Events

News - 2006-2007

	CBI Fact Sheet
	May 29, 2007 Contrarian Shopping List, from The Motley Fool, May 29, 2007
	August 09, 2006 Fairfax Identity Laboratories’, a division of Commonwealth Biotechnologies, Inc, testifies at Farrington Trial

Press Releases - 2007-2008

	March 06, 2008 Patent Issued to Commonwealth Biotechnologies, Inc. for Real Time PCR Analysis of the Different Human Herpes Viruses
	January 21, 2008 CBI Services is Accredited by the Laboratory Response Network of Bioterrorism
	December 28, 2007 Commonwealth Biotechnologies Inc. Business Unit, Fairfax Identity Laboratories, Gains International ISO 17025 Accreditation for DNA Forensic Services
	December 28, 2007 New Private and Government Sector Projects at CBI Services
	December 27, 2007 Exelgen announces partnerships with two leading European Biotechnology companies
	December 10, 2007 Commonwealth Biotechnologies Completes Integration Program for its Complementary Drug Discovery Businesses
	December 07, 2007 Commonwealth Biotechnologies Announces Appointment of Mark Hober to Vice President, Business Development and Marketing
	November 28, 2007 Tripos Discovery Research, a Subsidiary of Commonwealth Biotechnologies, Announces Name Change to Exelgen, Ltd.
	November 15, 2007 CBI Services Announces $2.9 Million in New Contracts
	November 14, 2007 Commonwealth Biotechnologies, Inc. Announces Third Quarter Results: Continues Triple-Digit Growth in Revenues of $2.97 Million, Signed New Contracts Worth Over $4.3 Million
	November 06, 2007 Tripos Discovery Research, a Subsidiary of Commonwealth Biotechnologies, Announces Collaboration with Schering-Plough for Design and Synthesis of Novel Compounds
	October 11, 2007 CBI Services and FIL Announce Third Quarter Contract Signings
	October 09, 2007 Mimotopes Pty Ltd, a Subsidiary of Commonwealth Biotechnologies Inc., Enters into Drug Development Licensing Agreement with Baker Heart Research Institute.
	September 27, 2007 Commonwealth Biotechnologies, Inc. Provides Market Update
	August 28, 2007 Tripos Discovery Research, a Subsidiary of Commonwealth Biotechnologies, Enters Agreement with CombinatoRx to Optimize Novel Compounds
	August 23, 2007 Corrected: COMMONWEALTH BIOTECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS THROUGH JUNE, 2007
	August 23, 2007 Commonwealth Biotechnologies, Inc. Reports Financial Results Through June, 2007
	August 20, 2007 Commonwealth Biotechnologies, Inc. Second Quarter and Year to Date Financial Results Through June, 2007
	August 09, 2007 Tripos Discovery Research, Ltd., a subsidiary of Commonwealth Biotechnologies, Inc., signs Library Analysis Agreement with Elan Pharmaceuticals, Inc.
	August 06, 2007 Tripos Discovery Research, a subsidiary of Commonwealth Biotechnologies, Inc. secures a Discovery Milestone Payment from Gemin X Biotechnologies Inc.
	July 03, 2007 Commonwealth Biotechnologies’ President Dr. Robert B. Harris Selected As Executive of the Week by the Homeland Security Portal
	June 27, 2007 Commonwealth Biotechnologies, Inc. Receives Centers for Disease Control and Prevention (CDC) Approval to Work on Avian Flu Virus
	June 21, 2007 Commonwealth Biotechnologies, Inc. Announces New Contracts
	June 06, 2007 Commonwealth Biotechnologies, Inc. Completes Acquisition of Tripos Discovery Research Ltd
	May 30, 2007 Mimotopes Pty Ltd and GlycoSyn IRL are awarded NZ $715,000 to build specialist GMP peptide capabilities
	May 16, 2007 Commonwealth Biotechnologies, Inc. Announces Definitive Agreement to Acquire Tripos Discovery Research Ltd
	March 23, 2007 Senior Vice President of Genzyme Pharmaceuticals joins CBI Board
	February 12, 2007 Commonwealth Biotechnologies, Inc. Completes Acquisition of Mimotopes Pty Ltd
	November 28, 2006 Commonwealth Biotechnologies, Inc. Announces Signing of Stock Purchase Agreement to Acquire Mimotopes Pty Ltd
	November 10, 2006 Commonwealth Biotechnologies, Inc. Reports Financial Results Through September, 2006
	September 12, 2006 Commonwealth Biotechnologies, Inc. Announces New Contracts
	July 26, 2006 Commonwealth Biotechnologies, Inc. Signs Term Sheet to Acquire Mimotopes Pty Ltd
	July 17, 2006 Commonwealth Biotechnologies, Inc. and PharmAust, Limited. Launch Strategic Alliance Agreement
	June 26, 2006 Commonwealth Biotechnologies, Inc. Director Plans Sale of Stock - Personal Situation Requires Asset Liquidation
	May 30, 2006 Commonwealth Biotechnologies, Inc. to Present at the Wall Street Analyst Forum
	May 25, 2006 Commonwealth Biotechnologies, Inc. to Present at the Wall Street Analyst Forum
	May 25, 2006 Commonwealth Biotechnologies, Inc. Announces Appointment of Senior Vice President, Sales, Marketing, and Business Development
	May 04, 2006 Commonwealth Biotechnologies, Inc. Reports Financial Results for the First Quarter of 2006
	February 22, 2006 Commonwealth Biotechnologies, Inc. and the Center for Functional Genomics Sign Strategic Alliance Agreement
	February 08, 2006 2005 Revenues for Commonwealth Biotechnologies, Inc. Reach $ 7.8 Million
	January 05, 2006 Commonwealth Biotechnologies, Inc. and Prism Pharmaceuticals, Inc., Enter into License Agreement to Develop Helix-Based Peptide Technologies

Robert B. Harris, President, selected as Executive of the Week by the Homeland Security Portal.

Commonwealth Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 (800-RELY-CBI) FAX: 804-648-2641
email: [email protected]